- Today
- Holidays
- Birthdays
- Reminders
- Cities
- Atlanta
- Austin
- Baltimore
- Berwyn
- Beverly Hills
- Birmingham
- Boston
- Brooklyn
- Buffalo
- Charlotte
- Chicago
- Cincinnati
- Cleveland
- Columbus
- Dallas
- Denver
- Detroit
- Fort Worth
- Houston
- Indianapolis
- Knoxville
- Las Vegas
- Los Angeles
- Louisville
- Madison
- Memphis
- Miami
- Milwaukee
- Minneapolis
- Nashville
- New Orleans
- New York
- Omaha
- Orlando
- Philadelphia
- Phoenix
- Pittsburgh
- Portland
- Raleigh
- Richmond
- Rutherford
- Sacramento
- Salt Lake City
- San Antonio
- San Diego
- San Francisco
- San Jose
- Seattle
- Tampa
- Tucson
- Washington
Manhasset Today
By the People, for the People
Feinstein Institutes Awards 2026 Ross Prize
Drs. Michel Sadelain and Carl H. June recognized for pioneering work in cell therapy
Apr. 2, 2026 at 7:27pm
Got story updates? Submit your updates here. ›
The Ross Prize honors pioneering research that harnesses the body's own immune defenses to fight disease.Manhasset TodayThe Feinstein Institutes for Medical Research has awarded the 2026 Ross Prize to Drs. Michel Sadelain and Carl H. June for their groundbreaking contributions to the field of cell therapy. The prestigious award honors their pivotal research and innovations that have transformed the treatment of various diseases.
Why it matters
The Ross Prize is one of the most prestigious honors in the medical research community, recognizing individuals whose work has had a transformative impact on human health. Drs. Sadelain and June's pioneering efforts in cell therapy have opened up new frontiers in treating cancer, autoimmune disorders, and other debilitating conditions, offering hope to countless patients.
The details
Drs. Sadelain and June have been at the forefront of developing revolutionary cell-based therapies. Dr. Sadelain's groundbreaking work in engineering chimeric antigen receptor (CAR) T cells has led to the development of highly effective treatments for blood cancers. Dr. June's research on T cell activation and expansion has been instrumental in advancing immunotherapy approaches that harness the body's own immune system to fight disease.
- The 2026 Ross Prize was awarded on April 2, 2026.
The players
Feinstein Institutes for Medical Research
A leading medical research organization dedicated to advancing scientific discoveries and improving human health.
Dr. Michel Sadelain
A renowned researcher and director of the Center for Cell Engineering at Memorial Sloan Kettering Cancer Center, recognized for his pioneering work in CAR T cell therapy.
Dr. Carl H. June
A professor of Immunotherapy at the University of Pennsylvania and a pioneer in the field of T cell-based immunotherapy, known for his groundbreaking research on T cell activation and expansion.
What they’re saying
“We are honored to receive this prestigious award, which recognizes the transformative potential of cell-based therapies. Our work is driven by the desire to improve the lives of patients and push the boundaries of what is possible in medicine.”
— Dr. Michel Sadelain, Director, Center for Cell Engineering, Memorial Sloan Kettering Cancer Center
“This award is a testament to the incredible progress our field has made in harnessing the power of the immune system to fight disease. We are grateful for the support and collaboration that has enabled us to advance these life-changing therapies.”
— Dr. Carl H. June, Professor of Immunotherapy, University of Pennsylvania
What’s next
The Feinstein Institutes will host a special ceremony on May 15, 2026, to formally present the Ross Prize to Drs. Sadelain and June, where they will deliver keynote addresses on the future of cell therapy research.
The takeaway
The recognition of Drs. Sadelain and June's pioneering work in cell therapy underscores the immense potential of this field to transform the treatment of a wide range of diseases. Their groundbreaking research has paved the way for more effective and personalized therapies, offering hope to patients and advancing the frontiers of medical science.
